Crews KR - Search Results

1

Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia.

Montefiori LE, Bendig S, Gu Z, Chen X, Pölönen P, Ma X, Murison A, Zeng A, Garcia-Prat L, Dickerson K, Iacobucci I, Abdelhamed S, Hiltenbrand R, Mead PE, Mehr CM, Xu B, Cheng Z, Chang TC, Westover T, Ma J, Stengel A, Kimura S, Qu C, Valentine MB, Rashkovan M, Luger S, Litzow MR, Rowe JM, den Boer ML, Wang V, Yin J, Kornblau SM, Hunger SP, Loh ML, Pui CH, Yang W, Crews KR, Roberts KG, Yang JJ, Relling MV, Evans WE, Stock W, Paietta EM, Ferrando AA, Zhang J, Kern W, Haferlach T, Wu G, Dick JE, Klco JM, Haferlach C, Mullighan CG. Montefiori LE, et al. Among authors: crews kr. Cancer Discov. 2021 Nov;11(11):2846-2867. doi: 10.1158/2159-8290.CD-21-0145. Epub 2021 Jun 8. Cancer Discov. 2021. PMID: 34103329 Free PMC article.

2

Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.

Crews KR, Gandhi V, Srivastava DK, Razzouk BI, Tong X, Behm FG, Plunkett W, Raimondi SC, Pui CH, Rubnitz JE, Stewart CF, Ribeiro RC. Crews KR, et al. J Clin Oncol. 2002 Oct 15;20(20):4217-24. doi: 10.1200/JCO.2002.10.006. J Clin Oncol. 2002. PMID: 12377965 Clinical Trial.

3

Epigenetic regulation of human gamma-glutamyl hydrolase activity in acute lymphoblastic leukemia cells.

Cheng Q, Cheng C, Crews KR, Ribeiro RC, Pui CH, Relling MV, Evans WE. Cheng Q, et al. Among authors: crews kr. Am J Hum Genet. 2006 Aug;79(2):264-74. doi: 10.1086/505645. Epub 2006 Jun 6. Am J Hum Genet. 2006. PMID: 16826517 Free PMC article.

4

Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia.

Stocco G, Cheok MH, Crews KR, Dervieux T, French D, Pei D, Yang W, Cheng C, Pui CH, Relling MV, Evans WE. Stocco G, et al. Among authors: crews kr. Clin Pharmacol Ther. 2009 Feb;85(2):164-72. doi: 10.1038/clpt.2008.154. Epub 2008 Aug 6. Clin Pharmacol Ther. 2009. PMID: 18685564 Free PMC article.

5

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.

Yang JJ, Bhojwani D, Yang W, Cai X, Stocco G, Crews K, Wang J, Morrison D, Devidas M, Hunger SP, Willman CL, Raetz EA, Pui CH, Evans WE, Relling MV, Carroll WL. Yang JJ, et al. Blood. 2008 Nov 15;112(10):4178-83. doi: 10.1182/blood-2008-06-165027. Epub 2008 Sep 2. Blood. 2008. PMID: 18768390 Free PMC article.

6

Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia.

Crews KR, Zhou Y, Pauley JL, Howard SC, Jeha S, Relling MV, Pui CH. Crews KR, et al. Cancer. 2010 Jan 1;116(1):227-32. doi: 10.1002/cncr.24681. Cancer. 2010. PMID: 19834958 Free PMC article.

7

Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia.

Inaba H, Stewart CF, Crews KR, Yang S, Pounds S, Pui CH, Rubnitz JE, Razzouk BI, Ribeiro RC. Inaba H, et al. Among authors: crews kr. Cancer. 2010 Jan 1;116(1):98-105. doi: 10.1002/cncr.24712. Cancer. 2010. PMID: 19885837 Free PMC article. Clinical Trial.

8

Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.

Stocco G, Crews KR, Evans WE. Stocco G, et al. Among authors: crews kr. Expert Opin Drug Saf. 2010 Jan;9(1):23-37. doi: 10.1517/14740330903426151. Expert Opin Drug Saf. 2010. PMID: 20021291 Review.

9

A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.

Chen SH, Yang W, Fan Y, Stocco G, Crews KR, Yang JJ, Paugh SW, Pui CH, Evans WE, Relling MV. Chen SH, et al. Among authors: crews kr. Leukemia. 2011 Jan;25(1):66-74. doi: 10.1038/leu.2010.256. Epub 2010 Nov 12. Leukemia. 2011. PMID: 21072045 Free PMC article.

10

Development and implementation of a pharmacist-managed clinical pharmacogenetics service.

Crews KR, Cross SJ, McCormick JN, Baker DK, Molinelli AR, Mullins R, Relling MV, Hoffman JM. Crews KR, et al. Am J Health Syst Pharm. 2011 Jan 15;68(2):143-50. doi: 10.2146/ajhp100113. Am J Health Syst Pharm. 2011. PMID: 21200062 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page